The Resource Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017
Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017
Resource Information
The item Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017 represents a specific, individual, material embodiment of a distinct intellectual or artistic creation found in Indiana State Library.This item is available to borrow from 1 library branch.
Resource Information
The item Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017 represents a specific, individual, material embodiment of a distinct intellectual or artistic creation found in Indiana State Library.
This item is available to borrow from 1 library branch.
- Language
- eng
- Extent
- v, 136 pages
- Note
-
- Shipping list no.: 2019-0072-P
- "Serial No. 115-10."
- Label
- Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017
- Title
- Examining FDA's generic drug and biosimilar user fee programs
- Title remainder
- hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017
- Title variation
- Examining Food and Drug Administration's generic drug and biosimilar user fee programs
- Subject
-
- Generic drugs -- Prices -- United States
- Prescription pricing -- Law and legislation -- United States
- Drug accessibility -- Government policy -- United States
- User charges -- Law and legislation -- United States
- United States, Food and Drug Administration -- Rules and practice
- Drugs -- Law and legislation -- United States
- Language
- eng
- Cataloging source
- SEN
- Government publication
- federal national government publication
- Illustrations
- illustrations
- Index
- no index present
- Literary form
- non fiction
- Nature of contents
- bibliography
- http://bibfra.me/vocab/lite/organizationName
- United States
- http://library.link/vocab/subjectName
-
- United States
- Generic drugs
- Prescription pricing
- User charges
- Drug accessibility
- Drugs
- Target audience
- general
- Label
- Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017
- Note
-
- Shipping list no.: 2019-0072-P
- "Serial No. 115-10."
- Bibliography note
- Includes bibliographical references
- Carrier category
- volume
- Carrier category code
- nc
- Carrier MARC source
- rdacarrier
- Content category
- text
- Content type code
- txt
- Content type MARC source
- rdacontent
- Control code
- 21659778
- Dimensions
- 24 cm
- Extent
- v, 136 pages
- Media category
- unmediated
- Media MARC source
- rdamedia
- Media type code
- n
- Other physical details
- illustrations
- System control number
-
- (OCoLC)1078699092
- tmp97457281
- Label
- Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017
- Note
-
- Shipping list no.: 2019-0072-P
- "Serial No. 115-10."
- Bibliography note
- Includes bibliographical references
- Carrier category
- volume
- Carrier category code
- nc
- Carrier MARC source
- rdacarrier
- Content category
- text
- Content type code
- txt
- Content type MARC source
- rdacontent
- Control code
- 21659778
- Dimensions
- 24 cm
- Extent
- v, 136 pages
- Media category
- unmediated
- Media MARC source
- rdamedia
- Media type code
- n
- Other physical details
- illustrations
- System control number
-
- (OCoLC)1078699092
- tmp97457281
Subject
- Generic drugs -- Prices -- United States
- Prescription pricing -- Law and legislation -- United States
- Drug accessibility -- Government policy -- United States
- User charges -- Law and legislation -- United States
- United States, Food and Drug Administration -- Rules and practice
- Drugs -- Law and legislation -- United States
Embed
Settings
Select options that apply then copy and paste the RDF/HTML data fragment to include in your application
Embed this data in a secure (HTTPS) page:
Layout options:
Include data citation:
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.library.in.gov/portal/Examining-FDAs-generic-drug-and-biosimilar-user/l4mRPO1JmXs/" typeof="Book http://bibfra.me/vocab/lite/Item"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.library.in.gov/portal/Examining-FDAs-generic-drug-and-biosimilar-user/l4mRPO1JmXs/">Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.library.in.gov/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.library.in.gov/">Indiana State Library</a></span></span></span></span></div>
Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements
Preview
Cite Data - Experimental
Data Citation of the Item Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017
Copy and paste the following RDF/HTML data fragment to cite this resource
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.library.in.gov/portal/Examining-FDAs-generic-drug-and-biosimilar-user/l4mRPO1JmXs/" typeof="Book http://bibfra.me/vocab/lite/Item"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.library.in.gov/portal/Examining-FDAs-generic-drug-and-biosimilar-user/l4mRPO1JmXs/">Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.library.in.gov/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.library.in.gov/">Indiana State Library</a></span></span></span></span></div>
